Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Truist Securities reiterated its Buy rating on Bank of America Corporation PFD SER B 7% (OTC:BACRP) on October 15, 2026.
Read moreRBC Capital reiterated its Outperform rating on Bank of America Corporation PFD SER B 7% (OTC:BACRP) on October 15, 2026.
Read moreTD Cowen reiterated its Buy rating on Microsoft Corporation (NASDAQ:MSFT) on October 15, 2026.
Read moreCitigroup reiterated its Buy rating on Microsoft Corporation (NASDAQ:MSFT) on October 15, 2026.
Read moreMizuho reiterated its Outperform rating on Microsoft Corporation (NASDAQ:MSFT) on October 15, 2026.
Read moreJefferies reiterated its Buy rating on Microsoft Corporation (NASDAQ:MSFT) on October 15, 2026.
Read moreUBS reiterated its Buy rating on Microsoft Corporation (NASDAQ:MSFT) on October 15, 2026.
Read moreJP Morgan reiterated its Overweight rating on Alphabet Inc. (NASDAQ:GOOG) on October 15, 2026.
Read moreJP Morgan reiterated its Overweight rating on Alphabet Inc. (NASDAQ:GOOGL) on October 15, 2026.
Read moreBTIG reiterated its Buy rating on Twilio Inc. (NYSE:TWLO) on October 16, 2026.
Read moreBTIG reiterated its Buy rating on Prologis, Inc. (NYSE:PLD) on October 16, 2026.
Read morePiper Sandler reiterated its Overweight rating on ServiceNow, Inc. (NYSE:NOW) on October 16, 2026.
Read moreAmerx reiterated its Buy rating on WidePoint Corporation (AMEX:WYY) on October 15, 2026.
Read moreRBC Capital reiterated its Sector Perform rating on Smith Douglas Homes Corp. (NYSE:SDHC) on October 15, 2026.
Read moreMorgan Stanley reiterated its Underweight rating on AMC Networks Inc. (NASDAQ:AMCX) on October 15, 2026.
Read moreRaymond James analysts initiated coverage on First Financial Bankshares, Inc. (NASDAQ:FFIN) with a rating of Market Perform on October 15, 2026.
Read moreRBC Capital reiterated its Sector Perform rating on KB Home (NYSE:KBH) on October 15, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on Arrowhead Pharmaceuticals, Inc.
Read moreChardan Capital reiterated its Buy rating on Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) on October 15, 2026.
Read moreMorgan Stanley reiterated its Overweight rating on Permian Resources Corporation (NYSE:PR) on October 15, 2026.
Read more
